chrX-68433009-G-C
Variant summary
Our verdict is Benign. Variant got -14 ACMG points: 0P and 14B. BP4_StrongBP6_Very_StrongBP7BS2_Supporting
The NM_002547.3(OPHN1):āc.12C>Gā(p.Pro4Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000034 in 1,204,769 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 14 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Consequence
NM_002547.3 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -14 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OPHN1 | NM_002547.3 | c.12C>G | p.Pro4Pro | synonymous_variant | 2/25 | ENST00000355520.6 | NP_002538.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OPHN1 | ENST00000355520.6 | c.12C>G | p.Pro4Pro | synonymous_variant | 2/25 | 1 | NM_002547.3 | ENSP00000347710.5 |
Frequencies
GnomAD3 genomes AF: 0.0000979 AC: 11AN: 112378Hom.: 0 Cov.: 24 AF XY: 0.0000579 AC XY: 2AN XY: 34544
GnomAD3 exomes AF: 0.0000535 AC: 9AN: 168097Hom.: 0 AF XY: 0.0000551 AC XY: 3AN XY: 54489
GnomAD4 exome AF: 0.0000275 AC: 30AN: 1092391Hom.: 0 Cov.: 30 AF XY: 0.0000335 AC XY: 12AN XY: 358363
GnomAD4 genome AF: 0.0000979 AC: 11AN: 112378Hom.: 0 Cov.: 24 AF XY: 0.0000579 AC XY: 2AN XY: 34544
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Athena Diagnostics | Oct 18, 2016 | - - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 30, 2019 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 09, 2023 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at